The number of people with susceptibility test result for rifampicin in Indonesia
Indonesia: The number of people with susceptibility test result for rifampicin was 144,511 in 2021. ▲ Rising
Latest (2021)
144,511
Change on year
up 47.7%
World rank
3rd
of 155 countries
All-time high
144,511
in 2021
All-time low
17,138
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Indonesia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Indonesia is 144,511, measured in 2021. That is the highest value across all 5 years on record.
The figure is up 47.7% on the previous year and up 743.2% over five years.
That places Indonesia 3rd out of 155 countries with data for 2021, putting it in the top 10%.
The number of people with susceptibility test result for rifampicin in Indonesia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 17,138 | — |
| 2018 | 71,101 | +314.9% |
| 2019 | 125,741 | +76.8% |
| 2020 | 97,846 | -22.2% |
| 2021 | 144,511 | +47.7% |
Indonesia compared with similar countries
- Indonesia's 144,511 is above the median for upper middle income countries, which is 880, 164.2× the median. (46 countries reporting)
- Indonesia's 144,511 is above the median for East Asia & Pacific, which is 185, 781.1× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 71,327 | 17,138 | 125,741 | 3 |
| 2020s | 121,178 | 97,846 | 144,511 | 2 |
Countries ranked near Indonesia
More health data for Indonesia
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4924 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,286 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,463 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 50 (2025)
- Population ages 00-04, female, annual growth rate -0.5792 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0376 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5519 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Indonesia?
- The number of people with susceptibility test result for rifampicin in Indonesia was 144,511 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Indonesia?
- The highest recorded value was 144,511 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Indonesia?
- The lowest recorded value was 17,138 in 2017.
- How does Indonesia rank for the number of people with susceptibility test result for rifampicin?
- Indonesia ranks 3rd out of 155 countries with data for 2021.
- Where does this Indonesia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).